PetVivo Holdings, Inc. (PETV) stock
PETVOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$0.75+0.00 (0.00%)
Close on Oct 19, 2026Market cap $27.79MP/E –Yield –
PetVivo operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
PetVivo's operating income for the twelve months ending Jun 30, 2026 was -$8.83M. For fiscal 2026 it was -$9.06M. The highest annual figure on record is -$1.20M in fiscal 2015.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$9.06M | – |
| FY2025 | Mar 31, 2025 | -$8.06M | – |
| FY2024 | Mar 31, 2024 | -$10.62M | – |
| FY2023 | Mar 31, 2023 | -$8.73M | – |
| FY2022 | Mar 31, 2022 | -$5.06M | – |
| FY2021 | Mar 31, 2021 | -$1.96M | – |
| FY2020 | Mar 31, 2020 | -$2.02M | – |
| FY2019 | Mar 31, 2019 | -$4.67M | – |
| FY2018 | Mar 31, 2018 | -$2.29M | – |
| FY2017 | Mar 31, 2017 | -$16.39M | – |
| FY2016 | Mar 31, 2016 | -$3.25M | – |
| FY2015 | Mar 31, 2015 | -$1.20M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -$1.61M | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | -$2.96M | – |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | -$2.19M | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -$2.07M | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$1.84M | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$2.08M | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$1.76M | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$2.17M | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$2.04M | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$2.65M | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$2.13M | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -$2.94M | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$2.89M | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$2.33M | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$2.32M | – |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$2.12M | – |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -$1.97M | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$1.78M | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$1.66M | – |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | -$1.10M | – |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$518.52K | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -$312.96K | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -$385.39K | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | -$818.57K | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$442.07K | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$520.04K | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -$572.76K | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | -$429.61K | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$493.72K | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$1.29M | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | -$559.62K | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | -$727.59K | – |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$2.10M | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -$956.00K | – |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | -$532.89K | – |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | -$313.10K | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | -$483.32K | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | -$676.18K | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | -$498.54K | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | -$14.74M | – |
See a number that looks wrong?